Virtu Financial LLC Makes New Investment in agilon health, inc. (NYSE:AGL)

Virtu Financial LLC purchased a new stake in shares of agilon health, inc. (NYSE:AGL) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 30,610 shares of the company’s stock, valued at approximately $120,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in AGL. Geode Capital Management LLC increased its holdings in agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the period. Barclays PLC boosted its position in agilon health by 21.2% during the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after acquiring an additional 214,830 shares in the last quarter. XTX Topco Ltd increased its holdings in shares of agilon health by 271.1% in the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after acquiring an additional 87,481 shares during the period. State Street Corp raised its position in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in shares of agilon health during the 3rd quarter worth $261,000.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Citigroup cut their target price on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Stifel Nicolaus decreased their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Finally, Barclays lowered their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. Three analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $4.28.

Insider Activity

In other news, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Diana Mckenzie purchased 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 90,000 shares of company stock valued at $198,100 in the last quarter. 3.20% of the stock is currently owned by company insiders.

agilon health Stock Performance

AGL opened at $1.88 on Friday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.28. The firm has a 50 day moving average of $2.34 and a two-hundred day moving average of $4.28. The firm has a market capitalization of $774.59 million, a PE ratio of -2.00 and a beta of 0.51.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period last year, the business earned ($0.06) EPS. On average, analysts anticipate that agilon health, inc. will post -0.52 EPS for the current year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.